Insulin promoter factor 1 as target/marker of beta cell failure

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/68 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2574424

The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of IPF-1 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.

L'invention concerne la régulation de la progression d'une maladie et le diagnostic de la défaillance des cellules bêta chez des diabètes par mesure des niveaux d'IPF-1 dans un échantillon liquide, et par criblage de nouveaux composés pour la prévention et/ou le traitement du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Insulin promoter factor 1 as target/marker of beta cell failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin promoter factor 1 as target/marker of beta cell failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin promoter factor 1 as target/marker of beta cell failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1399756

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.